VitE-KGGk

General Information


DRACP ID  DRACP01084

Peptide Name   VitE-KGGk

Sequence  KGGk

Sequence Length  4

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse macrophage leukemia cell Leukemia LC50 >100 µM XTT assay 16 h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis=60 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Vitamin E succinate

C-terminal Modification  Amidation

Other Modification  k=D-Lys

Chiral  Mix



Physicochemical Information


Formula  C10H18N4O3

Absent amino acids  ACDEFHILMNPQRSTVWY

Common amino acids  G

Mass  29597

Pl  9.7

Basic residues  1

Acidic residues  0

Hydrophobic residues  0

Net charge  1

Boman Index  -367

Hydrophobicity  -117.5

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22006001

Title  Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B

Doi 10.1128/AAC.00468-11

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_16363

DRACP is developed by Dr.Zheng's team.